Rare Diseases
Latest News
3-D stereophotogrammetry helps detect progression of craniofacial morphea
Existing tools that detect disease progression in patients with CM are limited.
From the Journals
Anti-acid meds lower strength of systemic sclerosis drug
Weakened bioavailability of mycophenolate mofetil could require adjustments in treatment.
News from the FDA/CDC
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
From the Journals
Interstitial lung disease plus pulmonary hypertension equals poor outcomes in systemic sclerosis
Female sex and higher body mass index were associated with lower mortality risk.
Latest News
Mohs found to confer survival benefit in localized Merkel cell carcinoma
Results provide “preliminary data suggesting that treatment of localized, early-stage MCC with MMS may result in the most optimal patient survival...
News from the FDA/CDC
FDA okays first-ever new drug for rare bone disorder
The drug reduced annualized heterotopic ossification volume by 54%.
Opinion
A 75-year-old White woman presented with diffuse erythema, scale, and pruritus on her scalp
The patient also had periorbital erythema, as well as erythema on the distal interphalangeal joints.
Latest News
West Nile infections rising in the U.S.
West Nile Virus is the leading cause of mosquito-borne disease in the continental United States.
From the Journals
Autoantibody against enteric nervous system protein linked to GI dysfunction in systemic sclerosis
If validated as a biomarker, antigephyrin autoantibodies could help identify patients at higher risk for GI symptoms like constipation.
Latest News
Progress seen on five fronts for substantially improving treatment of epidermolysis bullosa
Progress on multiple fronts for control of disease or its symptoms suggests “we are on the cusp of a new era.”
Latest News
In new era of gene therapy, PCPs are ‘boots on the ground’
Pediatricians and general practitioners will be central to finding and monitoring the patients that need these treatments.